Logo image of NOTE

FISCALNOTE HOLDINGS INC (NOTE) Stock Fundamental Analysis

NYSE:NOTE - New York Stock Exchange, Inc. - US3376551046 - Common Stock - Currency: USD

0.6527  +0.01 (+1.04%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NOTE. NOTE was compared to 82 industry peers in the Professional Services industry. NOTE may be in some trouble as it scores bad on both profitability and health. NOTE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NOTE has reported negative net income.
In the past year NOTE has reported a negative cash flow from operations.
In the past 5 years NOTE reported 4 times negative net income.
NOTE had a negative operating cash flow in each of the past 5 years.
NOTE Yearly Net Income VS EBIT VS OCF VS FCFNOTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

The Return On Assets of NOTE (2.92%) is comparable to the rest of the industry.
NOTE has a Return On Equity of 9.73%. This is comparable to the rest of the industry: NOTE outperforms 53.66% of its industry peers.
Industry RankSector Rank
ROA 2.92%
ROE 9.73%
ROIC N/A
ROA(3y)-28.25%
ROA(5y)-39.12%
ROE(3y)-141.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOTE Yearly ROA, ROE, ROICNOTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

NOTE has a Profit Margin of 7.91%. This is in the better half of the industry: NOTE outperforms 75.61% of its industry peers.
NOTE's Gross Margin of 85.92% is amongst the best of the industry. NOTE outperforms 92.68% of its industry peers.
In the last couple of years the Gross Margin of NOTE has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 7.91%
GM 85.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5YN/A
NOTE Yearly Profit, Operating, Gross MarginsNOTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

2

2. Health

2.1 Basic Checks

NOTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
NOTE has more shares outstanding than it did 1 year ago.
The debt/assets ratio for NOTE has been reduced compared to a year ago.
NOTE Yearly Shares OutstandingNOTE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
NOTE Yearly Total Debt VS Total AssetsNOTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NOTE has an Altman-Z score of -3.13. This is a bad value and indicates that NOTE is not financially healthy and even has some risk of bankruptcy.
NOTE has a Altman-Z score of -3.13. This is amonst the worse of the industry: NOTE underperforms 89.02% of its industry peers.
A Debt/Equity ratio of 1.50 is on the high side and indicates that NOTE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.50, NOTE is doing worse than 80.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Altman-Z -3.13
ROIC/WACCN/A
WACC9.42%
NOTE Yearly LT Debt VS Equity VS FCFNOTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.12 indicates that NOTE should not have too much problems paying its short term obligations.
NOTE has a Current ratio of 1.12. This is comparable to the rest of the industry: NOTE outperforms 40.24% of its industry peers.
A Quick Ratio of 1.12 indicates that NOTE should not have too much problems paying its short term obligations.
NOTE has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
NOTE Yearly Current Assets VS Current LiabilitesNOTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

NOTE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.53%.
Looking at the last year, NOTE shows a decrease in Revenue. The Revenue has decreased by -9.33% in the last year.
NOTE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.20% yearly.
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.29%
Revenue 1Y (TTM)-9.33%
Revenue growth 3Y13.2%
Revenue growth 5YN/A
Sales Q2Q%-14.33%

3.2 Future

The Earnings Per Share is expected to decrease by -176.48% on average over the next years. This is quite bad
The Revenue is expected to grow by 7.03% on average over the next years.
EPS Next Y-717.1%
EPS Next 2Y-176.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.51%
Revenue Next 2Y7.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NOTE Yearly Revenue VS EstimatesNOTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
NOTE Yearly EPS VS EstimatesNOTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -1 -2 -3 -4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOTE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOTE Price Earnings VS Forward Price EarningsNOTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOTE Per share dataNOTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A cheap valuation may be justified as NOTE's earnings are expected to decrease with -176.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-176.48%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NOTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FISCALNOTE HOLDINGS INC

NYSE:NOTE (5/15/2025, 2:55:05 PM)

0.6527

+0.01 (+1.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners41.37%
Inst Owner Change2.12%
Ins Owners12.7%
Ins Owner Change27%
Market Cap100.93M
Analysts82
Price Target3 (359.63%)
Short Float %10.28%
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.06%
Min EPS beat(2)-11.56%
Max EPS beat(2)-0.55%
EPS beat(4)2
Avg EPS beat(4)81.22%
Min EPS beat(4)-11.56%
Max EPS beat(4)304.86%
EPS beat(8)4
Avg EPS beat(8)17.46%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.28%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.19%
Revenue beat(8)1
Avg Revenue beat(8)-1.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.07%
EPS NY rev (1m)0%
EPS NY rev (3m)14.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-22.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF N/A
P/OCF N/A
P/B 1.03
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.78
BVpS0.63
TBVpS-0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.92%
ROE 9.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 7.91%
GM 85.92%
FCFM N/A
ROA(3y)-28.25%
ROA(5y)-39.12%
ROE(3y)-141.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.71%
Cap/Sales 7.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z -3.13
F-Score6
WACC9.42%
ROIC/WACCN/A
Cap/Depr(3y)42.35%
Cap/Depr(5y)41.75%
Cap/Sales(3y)7.79%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.29%
EPS Next Y-717.1%
EPS Next 2Y-176.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.33%
Revenue growth 3Y13.2%
Revenue growth 5YN/A
Sales Q2Q%-14.33%
Revenue Next Year-19.51%
Revenue Next 2Y7.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year132.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y67.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.07%
OCF growth 3YN/A
OCF growth 5YN/A